Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer

Key facts

Sponsor

National Cancer Institute (NCI)

Principal Investigator

Jyoti S Mayadev, M.D

NRG Oncology

Intervention

Cisplatin(drug)

Enrollment

34 enrolled

Eligibility

18 years · FEMALE

Timeline

2012 – 2020

Study locations (16)

• Los Angeles County-USC Medical Center, Los Angeles, California, United States
• USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
• UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States
• University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
• Hartford Hospital, Hartford, Connecticut, United States
• The Hospital of Central Connecticut, New Britain, Connecticut, United States
• Augusta University Medical Center, Augusta, Georgia, United States
• University of New Mexico Cancer Center, Albuquerque, New Mexico, United States
• Montefiore Medical Center-Einstein Campus, The Bronx, New York, United States
• Case Western Reserve University, Cleveland, Ohio, United States
• Cleveland Clinic Foundation, Cleveland, Ohio, United States
• University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
• Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
• Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
• Women and Infants Hospital, Providence, Rhode Island, United States
• +1 more locations on ClinicalTrials.gov

Collaborators

NRG Oncology

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Adenocarcinoma of the cervix uteri

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT07276360
  Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda
  Uganda Cancer Institute
• RECRUITINGPHASE1NCT07454642
  AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
  Avacta Life Sciences Ltd
• RECRUITINGPHASE3NCT07061977
  Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
  National Cancer Institute (NCI)
• RECRUITINGNCT07359586
  Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
  Zhejiang University
• RECRUITINGPHASE1NCT07020117
  A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
  Aktis Oncology, Inc.
• RECRUITINGPHASE2NCT06654011
  IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 Trial
  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
• ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT07153952
  RT for Adenocarcinoma/Adenosquamous Carcinoma
  Peking Union Medical College Hospital
• RECRUITINGNCT06733740
  Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma
  Chinese PLA General Hospital

See all trials for Adenocarcinoma of the cervix uteri →